References
- Moldow RE, Conelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 1968; 55: 677–686
- Schein, PS, De Lellis, RA, Kahn, CR, et al. Islet cell tumors. Current concepts and management. Ann Int Med 1973; 79: 239–257
- Nicholls AG. Simple adenoma of the pancreas arising from an island of Langerhans. J Med Res 1902; 8: 385–395
- Graeme-Cook F, Nardi G, Compton C. Immunohistochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas. Am J Clin Pathol 1990; 93: 273–276
- Heitz, PU, Kasper, M, Kloppel, G, et al. Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: A specific marked for malignancy. Immunocytochemical analysis of tumors of 155 patients. Cancer 1983; 51: 277–282
- Heitz PU, Klöppel G. Pancreatic endocrine tumours. Evolution and tumour pathology of the neuroendocrine system, S Falkmer, R Hakanson, F Sundler. Elsevier Science Publishers, Amsterdam 1984; 481–496, In
- Oosterhuis, JW, Rammelo, RHU, Cornelisse, CJ, et al. Ploidy of malignant mediastinal germ-cell tumours. Human Pathol 1990; 21: 729–732
- Oosterhuis, JW, Castedo, SMMJ, De Jong, B, et al. Ploidy of subtypes of primary germ cell tumours of the testis. Pathogenetic and clinical relevance. Lab Invest 1989; 60: 14–21
- Friedlander, ML, Hedley, DW, Taylor, IW, et al. Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 1984; 44: 397–400
- Stipa, F, Arganini, M, Bibbo, M, et al. Nuclear DNA analysis of insulinomas and gastrinomas. Surgery 1987; 102(b)988–998
- Graeme-Cook, F, Bell, DA, Flotte, TJ, et al. Aneuploidy in pancreatic insulinomas does not predict malignancy. Cancer 1990; 66: 2365–2368
- Ericksson, B, Oberg, K, Wilander, E, et al. Nuclear DNA distribution in neuroendocrine gastroenteropancreatic tumours before and during treatment. Acta Oncologica 1989; 28: 193–197
- Lee, CS, Charlton, I, Williams, R, et al. Malignant potential of aneuploid pancreatic endocrine tumours. J Pathol, in press
- Kenny, BD, Sloan, JM, Hamilton, PW, et al. The role of morphometry in predicting prognosis in pancreatic islet cell tumours. Cancer 1989; 64: 460–465
- Jones DJ, Hasleton PS, Moore M. DNA ploidy in bronchopulmonary carcinoid tumours. Thorax 1988; 43: 195–199
- Hosaka, Y, Rainwater, LM, Grant, CS, et al. Phaeochromocytoma: Nucleus deoxyribonucleic acid patterns studied by flow cytometry. Surgery 1986; 100: 1003–1009
- Alanen, KA, Joensuu, H, Kleimi, PJ, et al. DNA ploidy in pancreatic neuroendocrine tumours. Am J Clin Pathol 1990; 93: 784–788
- Donow, C, Baisch, H, Heitz, PU, et al. Nuclear DNA content in 27 pancreatic endocrine tumors: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain. Virchows Arch (Anat Path) 1991; 419: 463–468
- Alanen, KA, Falkmer, UG, Klemi, PJ, et al. Flow and image cytometric study of pancreatic neuroendocrine tumours: frequent DNA aneuploidy and an association with the clinical outcome. Virchows Arch (Anat Path) 1992; 421: 121–125
- Ruschoff, J, Willemer, S, Brunzel, M, et al. Nucleolar organizer regions and glycoprotein-hormone alpha-chain reaction as markers of malignancy in endocrine tumours of the pancreas. Histopathol 1993; 22: 51–57
- Pelosi, G, Zamboni, G, Doglioni, C, et al. Immunodetection of proliferating cell nuclear antigen assess the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 1992; 16: 1215–1225